BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 18399314)

  • 1. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
    Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
    Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
    Fischer P; Kipp W; Bamuhiga J; Binta-Kahwa J; Kiefer A; Büttner DW
    Trop Med Parasitol; 1993 Dec; 44(4):311-21. PubMed ID: 8134773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela.
    Vivas-Martínez S; Basáñez MG; Botto C; Villegas L; García M; Curtis CF
    Parasitology; 2000 Nov; 121 Pt 5():527-34. PubMed ID: 11128804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.
    Remme J; Baker RH; De Sole G; Dadzie KY; Walsh JF; Adams MA; Alley ES; Avissey HS
    Trop Med Parasitol; 1989 Sep; 40(3):367-74. PubMed ID: 2617046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of vector microfilarial uptake as a comparatively non-invasive technique for monitoring onchocerciasis treatment campaigns in the Americas.
    Davies JB; Luján R; López-Martinez LA; Paniagua-Alvarez AJ; Morales-Hernández BE; Sherlock K
    Trop Med Int Health; 1997 Apr; 2(4):348-55. PubMed ID: 9171843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density-dependent processes in the transmission of human onchocerciasis: intensity of microfilariae in the skin and their uptake by the simuliid host.
    Basáñez MG; Boussinesq M; Prod'hon J; Frontado H; Villamizar NJ; Medley GF; Anderson RM
    Parasitology; 1994 Jan; 108 ( Pt 1)():115-27. PubMed ID: 8152850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of forest onchocerciasis in the Lower Cross River basin, Nigeria: entomologic profile after five years of ivermectin intervention.
    Opara KN; Fagbemi OB; Ekwe A; Okenu DM
    Am J Trop Med Hyg; 2005 Aug; 73(2):371-6. PubMed ID: 16103607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of Onchocerca volvulus transmission in Northern Venezuela.
    Convit J; Schuler H; Borges R; Olivero V; Domínguez-Vázquez A; Frontado H; Grillet ME
    Parasit Vectors; 2013 Oct; 6(1):289. PubMed ID: 24499653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments.
    Boussinesq M; Prod'hon J; Chippaux JP
    Trans R Soc Trop Med Hyg; 1997; 91(1):82-6. PubMed ID: 9093638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amazonian onchocerciasis: parasitological profiles by host-age, sex, and endemicity in southern Venezuela.
    Vivas-Martínez S; Basáñez MG; Botto C; Rojas S; García M; Pacheco M; Curtis CF
    Parasitology; 2000 Nov; 121 Pt 5():513-25. PubMed ID: 11128803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.
    Rodríguez-Pérez MA; Danis-Lozano R; Rodríguez MH; Bradley JE
    Trop Med Int Health; 1999 Feb; 4(2):98-104. PubMed ID: 10206263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerciasis in Gilgel Ghibe River Valley southwest Ethiopia.
    Taye A; Gebre-Michael T; Taticheff S
    East Afr Med J; 2000 Feb; 77(2):116-20. PubMed ID: 10774086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
    Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
    Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
    Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.